top of page

Press

Fluidx Medical Closes Financing to Advance Next-Generation Embolic Platforms

7 August 2026

Fluidx Completes Submission of Premarket Approval Application for the GPX® Embolic Device

24 July 2026

GPX® Embolic Device meets Primary Endpoints in an Investigational Device
Exemption (IDE) Pivotal Trial

14 July 2026

Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel

3 July 2026

bottom of page